You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

imatinib intolerant

Showing 1 - 25 of 1,103
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Aichi, Japan
    Novartis Investigative Site
Dec 6, 2020

Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

Completed
  • Chronic Myeloid Leukaemia
  • Rionero in Vulture, Potenza, Italy
  • +32 more
Oct 24, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in Worldwide (STI571)

Completed
Has Results
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Los Angeles, California
  • +27 more
Jul 1, 2021

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Bordeaux, Aquitaine, France
  • +11 more
Dec 6, 2020

Gastrointestinal Stromal Tumor Trial in Boston, Portland, Philadelphia (regorafenib)

Completed
Has Results
  • Gastrointestinal Stromal Tumor
  • Boston, Massachusetts
  • +3 more
Aug 7, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • +3 more
  • Duarte, California
  • +100 more
Jun 8, 2021

Second-line Pharmacotherapy Patterns and Outcomes of Advanced

Not yet recruiting
  • Gastrointestinal Stromal Tumors
    • Guangzhou, Guangdong, China
      The first affiliated hospital,Sun yat-sen university
    Jun 30, 2022

    Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

    Completed
    Has Results
    • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
    • Loma Linda, California
    • +35 more
    Mar 25, 2021

    Chronic Myeloid Leukemia Trial in New Zealand (Dasatinib, Imatinib)

    Recruiting
    • Chronic Myeloid Leukemia
    • Auckland, New Zealand
    • +8 more
    Mar 10, 2021

    Gastrointestinal Stromal Tumors Trial (Ripretinib, binimetinib)

    Withdrawn
    • Gastrointestinal Stromal Tumors
    • (no location specified)
    Dec 15, 2021

    BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib

    Active, not recruiting
    • Chronic Myeloid Leukemia
    • Dasatinib discontinuation
    • Rionero in Vulture, Potenza, Italy
    • +36 more
    Jan 4, 2022

    EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)

    Active, not recruiting
    • EGFR Gene Mutation
    • Nonsmall Cell Lung Cancer
    • Washington, District of Columbia
    • +1 more
    Jan 9, 2022

    Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

    Active, not recruiting
    • Leukemia, Myeloid, Chronic-Phase
    • Halle (Saale), Saxony-Anhalt, Germany
    • +9 more
    Sep 9, 2022

    Gastrointestinal Stromal Tumors Trial in Japan, United States (DS-6157a)

    Completed
    • Gastrointestinal Stromal Tumors
    • Boston, Massachusetts
    • +4 more
    Apr 7, 2022

    Chronic GVHD Trial in Israel, Italy (nilotinib)

    Completed
    • Chronic Graft Versus Host Disease
    • Tel Hashomer, Israel
    • +11 more
    Aug 19, 2021

    Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)

    Not yet recruiting
    • Chronic Myeloid Leukemia (CML)
    • Ponatinib 15mg QD
    • Ponatinib 30mg QD
    • Cagliari, Italy
    • +12 more
    Jan 31, 2021

    Chronyc Myeloid Leukemia Trial in Italy, Netherlands (Imatinib, Nilotinib)

    Active, not recruiting
    • Chronyc Myeloid Leukemia
    • Alessandria, Italy
    • +81 more
    Jan 4, 2022

    Gastrointestinal Stromal Tumor(GIST) Trial in China (Ripretinib, Sunitinib)

    Recruiting
    • Gastrointestinal Stromal Tumor(GIST)
    • Beijing, Beijing, China
    • +17 more
    Dec 17, 2020

    CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

    Recruiting
    • CML
    • +3 more
    • Asciminib add-on
    • +3 more
    • Augusta, Georgia
    • +46 more
    Jan 23, 2023

    Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

    Completed
    • Pancreas Cancer
    • +6 more
    • Rozzano, Milan, Italy
      Istituto Clinico Humanitas
    Sep 9, 2022

    Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

    Completed
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Angers, France
    • +9 more
    Aug 17, 2022